Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

CHIPIN

Financiado

Tissue engineering the tumour microenvironment to improve treatment of pancreati...

My vision is to address a clinical problem with a novel and transformative approach. Using my unique expertise in cell biology, tissue engineering and translational research I will design technology platforms to test new treatment... ver más

31/03/2026

IPF DRESDEN

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

LEIBNIZINSTITUT FUR POLYMERFORSCHUNG DRESDEN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-12-17

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2019-COG: ERC Consolidator Grant

I+D

Cerrada hace 5 años

0% 100%

2 Participantes

IPF DRESDEN

2.00M€ | Lider

CENBIMO SL EN LIQUIDACION

Proyectos interesantes

PancmiR Biomimetic collagen-based scaffolds for the study of pancrea... 200K€ Cerrado

Design2Guide Cell-instructive matrices to deconstruct tumour tissues 150K€ Cerrado

RTI2018-101071-B-I00 FACTORES DE TRANSCRIPCION EN CANCER DE PANCREAS: DE LA BIOLO... 399K€ Cerrado

RYC2021-031317-I Targeting fibrosis to reprogram the tumour microenvironment... 236K€ Cerrado

PID2020-120073GB-I00 MODIFICAR LA RIGIDEZ DEL TEJIDO CANCEROSO PARA DETENER SU PR... 125K€ Cerrado

SAF2010-16102 REGULACION MICROAMBIENTAL DE LA MIGRACION DE CELULAS TUMORAL... 94K€ Cerrado

Últimas noticias

25-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 52 concesiones

25-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 1 concesiones

25-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 6 concesiones

Duración del proyecto: 63 meses Fecha Inicio: 2020-12-17
Fecha Fin: 2026-03-31

Presupuesto del proyecto 2M€

Descripción del proyecto My vision is to address a clinical problem with a novel and transformative approach. Using my unique expertise in cell biology, tissue engineering and translational research I will design technology platforms to test new treatments for human pancreatic cancer. Pancreatic tumours are cancers of unmet medical need with 85% of patients dying within 9 months of diagnosis. To find better therapies, we need patient-specific models that mimic the biology of tumour tissues and target interactions between malignant and non-malignant cells. Biomimetic tissue engineering is a powerful approach to generate 3D cancer models, however, only a few scientists use these technologies. Most 3D cultures of human cells include reconstituted matrices that originate from murine tumours containing undefined amounts of extracellular matrix and growth factors. There is no tissue-engineered 3D model that allows control over patient-specific and biomechanical characteristics of the pancreatic tumour microenvironment. I hypothesise that 3D approaches that replicate the native tissue composition and biomechanical properties will behave like real tumours to provide clinically predictive platforms and to test novel treatments that target both malignant and non-malignant cells. To test my hypothesis, I will: •3D-print matrix and cellular elements of the microenvironment of human pancreatic tumours •Develop a cancer-on-a-chip model of liver metastasis •Compare the crosstalk of malignant and other microenvironment components with the human disease •Validate my new platforms with treatments in clinical trials and test novel combination treatments that slow down or reduce tumour growth. In a multidisciplinary project, I will use: •3D printing to build platforms composed of hydrogels, fibrous scaffolds and patient-derived cells •Extracellular matrix molecules for chemical crosslinking into hydrogels •Cancer-on-a-chip models to study tumour metastasis •Imaging, biomechanical and multi-omics analyses.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores